News Medical on MSN
ARPA-H project aims to end liver transplant shortage with 3D bioprinting
Researchers are developing functional, patient-specific livers using 3D bioprinting and stem cell technology to eliminate the ...
Hosted on MSN
World's first pig-to-human liver transplant offers new hope for organ failure treatment
A major medical milestone has been reached with the successful transplantation of a genetically engineered pig liver into a living human. The case, reported in the Journal of Hepatology, marks the ...
According to SNS Insider, Human Liver Model Market growth is driven by Advances in 3D cell culture, liver-on-chip platforms, and growing focus on drug safety and disease modeling.Austin, Texas, Jan.
A pig's liver has been transplanted into a human recipient for the first time in a ‘milestone’ for organ transfers between animals and people. Scientists in China used a liver taken from a seven-month ...
The funding, part of a new ARPA-H bioprinting initiative, aims to create transplant-ready organs—potentially within ...
Experimental transplant of gene-edited pig liver into human offers hope for new frontier of research
Doctors in China have become the first to report details about a transplant of a genetically modified pig liver into a human. The liver was transplanted last year into a person who was brain-dead, and ...
Researchers successfully implanted a genetically modified pig liver into a human, proving that such an organ can function for an extended period. The graft supported essential liver processes before ...
Surgeons have now published the first report of a gene-edited pig liver transplanted into a person. The liver, which came from a genetically modified pig, appeared to stay active, producing bile and ...
Human periportal assembloid, showcasing the three key cell types of the liver: portal fibroblasts (magenta), cholangiocytes (green), and hepatocyte nuclei (blue). All cell borders are delineated in ...
News Medical on MSN
First-in-human Drug Trial Lowers High Blood Fats
In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results